Search by Drug Name or NDC

    NDC 68462-0142-01 Clindamycin Hydrochloride 75 mg/1 Details

    Clindamycin Hydrochloride 75 mg/1

    Clindamycin Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GLENMARK PHARMACEUTICALS INC., USA. The primary component is CLINDAMYCIN HYDROCHLORIDE.

    Product Information

    NDC 68462-0142
    Product ID 68462-142_8e66de7a-d9d4-4562-bc99-80489d482da4
    Associated GPIs
    GCN Sequence Number 009341
    GCN Sequence Number Description clindamycin HCl CAPSULE 75 MG ORAL
    HIC3 W1K
    HIC3 Description LINCOSAMIDE ANTIBIOTICS
    GCN 40831
    HICL Sequence Number 004044
    HICL Sequence Number Description CLINDAMYCIN HCL
    Brand/Generic Generic
    Proprietary Name Clindamycin Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clindamycin Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 75
    Active Ingredient Units mg/1
    Substance Name CLINDAMYCIN HYDROCHLORIDE
    Labeler Name GLENMARK PHARMACEUTICALS INC., USA
    Pharmaceutical Class Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA216957
    Listing Certified Through 2024-12-31

    Package

    NDC 68462-0142-01 (68462014201)

    NDC Package Code 68462-142-01
    Billing NDC 68462014201
    Package 100 CAPSULE in 1 BOTTLE (68462-142-01)
    Marketing Start Date 2023-03-10
    NDC Exclude Flag N
    Pricing Information N/A